13-hydroxy-9-11-octadecadienoic-acid has been researched along with Rett-Syndrome* in 1 studies
1 other study(ies) available for 13-hydroxy-9-11-octadecadienoic-acid and Rett-Syndrome
Article | Year |
---|---|
13-HODE, 9-HODE and ALOX15 as potential players in Rett syndrome OxInflammation.
Mutations in the MECP2 gene are the main cause of Rett syndrome (RTT), a pervasive neurodevelopmental disorder, that shows also multisystem disturbances associated with a metabolic component. The aim of this study was to investigate whether an increased production of oxidized linoleic acid metabolites, specifically 9- and 13-hydroxyoctadecadienoic acids (HODEs), can contribute to the altered the redox and immune homeostasis, suggested to be involved in RTT. Serum levels of 9- and 13-HODEs were elevated in RTT and associated with the expression of arachidonate 15-Lipoxygenase (ALOX15) in peripheral blood mononuclear cells (PBMCs). Omega-3 polyunsaturated fatty acids supplementation has shown to lower HODEs levels in RTT. Statistically significant correlation was demonstrated between the increased plasma HODEs levels and the lipoprotein-associated phospholipase A2 (Lp-PLA2) activity. Collectively, these findings reinforce the concept of the key role played by lipid peroxidation in RTT, and the possible ability of omega-3 polyunsaturated fatty acids supplementation in improving the oxinflammation status in RTT. Topics: Adolescent; Adult; Arachidonate 15-Lipoxygenase; Case-Control Studies; Child; Female; Humans; Inflammation; Leukocytes, Mononuclear; Linoleic Acids; Linoleic Acids, Conjugated; Male; Rett Syndrome; Young Adult | 2019 |